These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12018574)

  • 1. 99mTc-labeled field bean protease inhibitor can function as an efficient tumor detecting agent.
    Murugesan S; Banerji AP; Noronha OP; Samuel AM; Fernandes AO
    Indian J Exp Biol; 2001 Aug; 39(8):742-7. PubMed ID: 12018574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and biological evaluation of the new chlorin photosensitizer T3,4BCPC for detection and treatment of tumors.
    Murugesan S; Shetty SJ; Srivastava TS; Samuel AM; Noronha OP
    J Photochem Photobiol B; 2002 Aug; 68(1):33-8. PubMed ID: 12208034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A technetium-99m-labelled cyclam acid porphyrin (CAP) for tumour imaging.
    Murugesa S; Shetty SJ; Srivastava TS; Noronha OP; Samuel AM
    Appl Radiat Isot; 2001 Nov; 55(5):641-6. PubMed ID: 11573797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-ethylenedicysteine-folate: a new tumor imaging agent. Synthesis, labeling and evaluation in animals.
    Ilgan S; Yang DJ; Higuchi T; Zareneyrizi F; Bayhan H; Yu D; Kim EE; Podoloff DA
    Cancer Biother Radiopharm; 1998 Dec; 13(6):427-35. PubMed ID: 10851435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Labelling, control and radiopharmacological evaluation of 99mTc-adenosine 5'-diphosphate (99mTc-ADP) as tumour seeking agent.
    León AS; Rey AM; Leon ET; Savio EO; Kremer C; Lacava CJ; Nappa AN; Chiozzone RN; Campos ED
    Q J Nucl Med; 1996 Jun; 40(2):170-5. PubMed ID: 8909102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-annexin V.
    Yang DJ; Azhdarinia A; Wu P; Yu DF; Tansey W; Kalimi SK; Kim EE; Podoloff DA
    Cancer Biother Radiopharm; 2001 Feb; 16(1):73-83. PubMed ID: 11279800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m-cyclam AK 2123: a novel marker for tumor hypoxia.
    Murugesan S; Shetty SJ; Noronha OP; Samuel AM; Srivastava TS; Nair CK; Kothari L
    Appl Radiat Isot; 2001 Jan; 54(1):81-8. PubMed ID: 11144256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of systemically administered radiolabeled epidermal growth factor as a brain tumor targeting agent.
    Yang W; Barth RF; Leveille R; Adams DM; Ciesielski M; Fenstermaker RA; Capala J
    J Neurooncol; 2001 Oct; 55(1):19-28. PubMed ID: 11804279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and renal handling of 99mTc-labeled peptides.
    Trejtnar F; Laznicek M; Laznickova A; Mather SJ
    J Nucl Med; 2000 Jan; 41(1):177-82. PubMed ID: 10647621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating histologic malignancy of primary brain tumors: pentavalent technetium-99m-DMSA.
    Hirano T; Otake H; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1997 Jan; 38(1):20-6. PubMed ID: 8998143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of benzopyrene-induced forestomach tumors by field bean protease inhibitor(s).
    Fernandes AO; Banerji AP
    Carcinogenesis; 1995 Aug; 16(8):1843-6. PubMed ID: 7634412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scintigraphic imaging of the hypoxia marker (99m)technetium-labeled 2,2'-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (99mTc-labeled HL-91; prognox): noninvasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid.
    Siim BG; Laux WT; Rutland MD; Palmer BN; Wilson WR
    Cancer Res; 2000 Aug; 60(16):4582-8. PubMed ID: 10969810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeling of epidermal growth factor with 99mTc and in vivo localization following intracerebral injection into normal and glioma-bearing rats.
    Capala J; Barth RF; Bailey MQ; Fenstermaker RA; Marek MJ; Rhodes BA
    Bioconjug Chem; 1997; 8(3):289-95. PubMed ID: 9177833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with field bean protease inhibitor can effectively repress ethylnitrosourea (ENU)-induced neoplasms of the nervous system in Sprague-Dawley rats.
    Banerji A; Fernandes A; Bane S
    Cancer Lett; 1998 Aug; 130(1-2):161-7. PubMed ID: 9751269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m(V)-DMSA and thallium-201 in brain tumor imaging: correlation with histology and malignant grade.
    Hirano T; Otake H; Kazama K; Wakabayashi K; Zama A; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1997 Nov; 38(11):1741-9. PubMed ID: 9374344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The field bean protease inhibitor can effectively suppress 7,12-dimethylbenz[a]anthracene-induced skin tumorigenesis in mice.
    Fernandes AO; Banerji AP
    Cancer Lett; 1996 Jul; 104(2):219-24. PubMed ID: 8665491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99mTc-ADP: a potential agent for in vivo tumor detection.
    León ET; Rey AM; Savio EO; López JJ; Kremer E; León AS
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):99-103. PubMed ID: 7632778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential labeling of glial and meningial brain tumors with [2-(14)C]acetate.
    Dienel GA; Popp D; Drew PD; Ball K; Krisht A; Cruz NF
    J Nucl Med; 2001 Aug; 42(8):1243-50. PubMed ID: 11483687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applicability of 99mTc-HL91, a putative hypoxic tracer, to detection of tumor hypoxia.
    Yutani K; Kusuoka H; Fukuchi K; Tatsumi M; Nishimura T
    J Nucl Med; 1999 May; 40(5):854-61. PubMed ID: 10319761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive assessment of tumor hypoxia with 99mTc labeled metronidazole.
    Yang DJ; Ilgan S; Higuchi T; Zareneyrizi F; Oh CS; Liu CW; Kim EE; Podoloff DA
    Pharm Res; 1999 May; 16(5):743-50. PubMed ID: 10350019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.